Upstream Processing

Jun 01, 2017
BioPharm International
An increase in biologics raises awareness of particle generation and its role in negative patient outcomes.
Jun 01, 2017
BioPharm International
This article summarizes the approaches, challenges, and future perspectives for the characterization of N-glycans in biopharmaceutical products.
May 01, 2017
BioPharm International
Improving the bioreactor growth environment increases the rigor of bioprocessing runs.
May 01, 2017
BioPharm International
Can bioprocessing runs be consistently replicated in an inherently variable production environment?
Apr 01, 2017
BioPharm International
OrlaSURF technology can be used for the development of target-binding assays to monitor the binding of an ADC to its antigen.
Mar 01, 2017
BioPharm International
The decision to use disposable bioreactors is now driven by commercial rather than technological considerations.
Feb 22, 2017
By BioPharm International Editors
CellGenix will add R&D, production, and warehouse space in Freiburg, Germany for GMP-grade raw materials for cell therapy, gene-therapy, and tissue-engineered products.
Feb 07, 2017
By BioPharm International Editors
This three-year partnership will explore and identify new tools and methods to modify and optimize the Chinese hamster ovary (CHO) cell line performance.
Feb 01, 2017
BioPharm International
A multi-pronged approach to raw materials testing can help mitigate the risk of future contamination events.
Jan 09, 2017
By BioPharm International Editors
UK-based Orchard Therapeutics and PharmaCell ally to support clinical trials and commercialization of Orchard’s ex-vivo gene therapies.
native1_300x100
lorem ipsum